150438-01-0

Basic information

• Product Name: 2-Propyl-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-5-[2-(2,2,2-trifluoro-acetyl)-pyrrol-1-yl]-3H-imidazole-4-carboxylic acid methyl ester
• Synonyms: 2-Propyl-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-5-[2-(2,2,2-trifluoro-acetyl)-pyrrol-1-yl]-3H-imidazole-4-carboxylic acid methyl ester
• CAS NO: 150438-01-0
• Molecular Weight: 563.539
• Mol File: 150438-01-0.mol

Chemical Properties

• CAS DataBase Reference: 2-Propyl-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-5-[2-(2,2,2-trifluoro-acetyl)-pyrrol-1-yl]-3H-imidazole-4-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propyl-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-5-[2-(2,2,2-trifluoro-acetyl)-pyrrol-1-yl]-3H-imidazole-4-carboxylic acid methyl ester(150438-01-0)
• EPA Substance Registry System: 2-Propyl-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-5-[2-(2,2,2-trifluoro-acetyl)-pyrrol-1-yl]-3H-imidazole-4-carboxylic acid methyl ester(150438-01-0)

Safety Data

• Hazardous Substances Data: 150438-01-0(Hazardous Substances Data)

Upstream product

• 150437-91-5 2-Propyl-5-[2-(2,2,2-trifluoro-acetyl)-pyrrol-1-yl]-3-[2'-(2-trityl-2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-imidazole-4-carboxylic acid methyl ester 
• 150437-95-9 methyl N-(N'-cyanobutyrimidoyl)glycinate 
• 150437-96-0 methyl 4-amino-2-propyl-1H-imidazole-5-carboxylate 
• 150437-97-1 methyl 2-propyl-4-(1H-pyrrol-1-yl)-1H-imidazole-5-carboxylate 
• 150437-98-2 methyl 2-propyl-5-<2-(trifluoroacetyl)-1H-pyrrol-1-yl>-1H-imidazole-4-carboxylate 

Downstream Products

• 150438-02-1 CI 996 

Relevant articles and documents

Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: Profile of 2-propyl-1-[[2'-(tetrazol-5-yl)-[1,1'-biphenyl]-4- yl]-methyl]-4-[2-(trifluoroace

A novel series of nonpeptide angiotensin II (AII) receptor antagonists containing a 1H-pyrrol-1-yl moiety at the 4-position of the imidazole have been developed. The pyrrole group occupies the same lipophilic pocket at the receptor as the chloro group in